Tryptase in diagnosing adverse suspected anaphylactic reaction

Advances in Clinical and Experimental Medicine

Volumn 21, Issue 3, 2012, Pages 403-408

  Michalska Krzanowska, Grazyna ^a  

^a Division of Anesthesiology and Intensive Care   (Poland)

Author keywords

Anaphylaxis; Anesthesia; Perioperative period; Tryptase

Indexed keywords

ANESTHETIC AGENT; ATRACURIUM; BENZYLISOQUINOLINE DERIVATIVE; CALCITONIN GENE RELATED PEPTIDE; CELL ENZYME; CHYMASE; CISATRACURIUM; EOSINOPHIL CHEMOTACTIC FACTOR; GLYCOSAMINOGLYCAN; HEPARIN; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 3; MIVACURIUM; PANCURONIUM; PEROXIDASE; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPASE C INHIBITOR; SEROTONIN; STEM CELL FACTOR; STEROID; SUPEROXIDE DISMUTASE; SUXAMETHONIUM; TETRAMER; TRYPTASE; VASOACTIVE INTESTINAL POLYPEPTIDE; VECURONIUM;

5Q- SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; ANAPHYLAXIS; ASTHMA; CELL HYPERPLASIA; CELL POPULATION; CHROMOSOME 16; DISEASE MARKER; DRUG EFFECT; ENZYME BLOOD LEVEL; FLUOROIMMUNOASSAY; FOLLOW UP; GASTROINTESTINAL MUCOSA; GENERAL ANESTHESIA; HAY FEVER; HEART INFARCTION; HEROIN DEPENDENCE; HISTOPATHOLOGY; HUMAN; HYPEREOSINOPHILIC SYNDROME; HYPOXIA; IN VITRO STUDY; INJURY; KIDNEY FAILURE; MAST CELL; MAST CELL DEGRANULATION; MASTOCYTOSIS; MYELODYSPLASTIC SYNDROME; NEUTROPHIL CHEMOTAXIS; PAIN; PEMPHIGOID; PERIOPERATIVE PERIOD; PH; PLASMA HALF LIFE; PRURITUS; REVIEW; RHEUMATOID ARTHRITIS; SCAR FORMATION; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; URTICARIA; WOUND HEALING;

EID: 84863741403     PISSN: 18995276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Hepner DL, Castells M: Anaphylaxis during the perioperative period. Anest Analg 2003, 97, 1381-1395. (Pubitemid 37310138)
2. Mertes PM, Laxenaire MC: Anaphylaxis during general anaesthesia - prevention and management. CNS Drugs 2000, 14, 115-133.
3. Guttormsen AB: Allergic reactions during anaesthesia - increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand 2001, 45, 1189-1190.
4. Kroigaard M, Garvey LH, Gillberg L, Johansson SG: Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 2007, 51, 655-670. (Pubitemid 46918542)
5. Harboe T, Guttormsen AB, Dybendal T: Anaphylaxis during anesthesia in Norway. Anesthesiology 2005, 102, 897-903.
6. Krishnaswamy G, Kelley J, Johanson D: The human mast cell: functions in physiology and disease. Frontiers Biosci 2001, 6, 1109-1127.
7. Gell PG, Coombs RA, Lachmann PF: Clinical aspects of immunology. In: Atopy. Ed.: Pepys J. Oxford, Blackwell Scientific. Ed 3 1975, 877-902.
8. Metcalfe DD, Baram D, Mekori YA: Mastcells. Physiol Rev 1997, 77, 1033-1079.
9. Galli SJ, Nakae S, Tsai M: Mast cell in the development of adaptive immune responses. Nat Immunol 2005, 6, 135-142. (Pubitemid 40268194)
10. He S, Xie H: Modulation of tryptase release from human tonsil mast cells by protease inhibitors. Pharmacol Rep 2005, 57, 523-530. (Pubitemid 41288694)
11. Payne V, Kam PCA: Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 2004, 59, 695-703. (Pubitemid 38997011)
12. Marone G: Human basophils and mast cells. Biological aspects. Dvorak AM ultrastructural analysis of human mast cells and basophils. Chem Immunol 1995, 61, 1-28.
13. Marone G: Human basophils and mast cells: Biological Aspects. MacGlashan DW - Signal transduction and cytokine production by human basophils. Chem Immunol Basel Karger 1995, 61, 88-113.
14. Pereira PJ, Bergner A, Macedo-Ribeiro S, Hubner R: Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 1998, 392, 306-311. (Pubitemid 28155107)
15. Hallgren J, Spillmann D, Pejler G: Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6: formation of active tryptase monomers in the presence of low molecular weight heparin. J Biol Chem 2001, 276, 42774-42781.
16. He SH, Xie H, He YS: Induction of tryptase and histamine release from human colon mast cells by IgE dependent or independent mechanisms. World J Gastroenterol 2004, 10, 319-322. (Pubitemid 38208078)
17. Veien M, Szlam F, Holden J, Levy J: Mechanism of nonimmunological histamine and tryptase release from human cutaneous mast cells. Anesthesiology 2000, 92, 1074-1081. (Pubitemid 30180985)
18. Stellato C, Paulis A, Cirillo R: Heterogeneity of human mast cells and basophils in response to muscle relaxants. Anaesthesiology 1991, 74, 1078-1086.
19. Enrique E, Garcia-Ortega P, Sotorra O: Usefulness of UniCAP tryptase fluoroimmunoassay in the diagnosis of anaphylaxis. Allergy 1999, 54, 602-606. (Pubitemid 29301816)
20. Schwartz LB, Yunginger JW, Miller J: Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989, 83, 1551-1555. (Pubitemid 19124110)
21. The Association of Anaesthetists of Great Britain and Ireland: Suspected anaphylactic reactions associated with anaesthesia, August 2003.
22. Lange M, Renke J, Gleń J: Tryptasa mastocytowa, interleukina 6 jako wykładnik ciȩżkości przebiegu mastocytozy. Post Dermatol Alergoz 2010, 27, 4, 238-245.
23. th ed. New York: McGraw-Hill 2001, 1919-1920.
24. Koppert W, Blunk J, Petersen L: Different patterns of mast cell activation by muscle relaxants in human skin. Anaesthesiology 2001, 95, 659-667.
25. Yunginger JW, Nelson DR: Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 1991, 36, 857-865.
26. Hallgren J, Pejler G: Biology of mast cell tryptase. FEBS J 2006, 273, 1871-1895.